Exact Mass: 478.2930382

Exact Mass Matches: 478.2930382

Found 500 metabolites which its exact mass value is equals to given mass value 478.2930382, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

MEGxp0_001993

Ipecac (Methylpsychotrine)

C29H38N2O4 (478.2831428)

Dehydroemetine

Ipecac (Dehydroemetine)

C29H38N2O4 (478.2831428)

P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01A - Agents against amoebiasis and other protozoal diseases C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent

(1R,4R,5R,8R,9S)-9-formyl-5-methyl-13-propan-2-yl-2-[[(2R,3S,4R,5S,6R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]tetracyclo[7.4.0.02,11.04,8]tridec-12-ene-1-carboxylic acid

C26H38O8 (478.2566548)

Polyporusterone A

14-(2,3-dihydroxy-5,6-dimethylheptan-2-yl)-4,5,11-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-9-en-8-one

C28H46O6 (478.3294216)

Polyporusterone A is found in mushrooms. Polyporusterone A is a constituent of Polyporus umbellatus (zhu ling). Constituent of Polyporus umbellatus (zhu ling). Polyporusterone A is found in mushrooms. Polyporusterone A is a triterpene carboxylic acid isolated from Polyporus umbellatus Fries. Polyporusterone A has inhibitory effect on free radical-induced lysis of red blood cells (hemolysis)[1]. Polyporusterone A is a triterpene carboxylic acid isolated from Polyporus umbellatus Fries. Polyporusterone A has inhibitory effect on free radical-induced lysis of red blood cells (hemolysis)[1].

Dolicholide

15-(3,4-dihydroxy-6-methyl-5-methylideneheptan-2-yl)-4,5-dihydroxy-2,16-dimethyl-9-oxatetracyclo[9.7.0.0²,⁷.0¹²,¹⁶]octadecan-8-one

C28H46O6 (478.3294216)

Dolicholide is found in common bean. Dolicholide is a constituent of Dolichos lablab (hyacinth bean).

25-Acetylvulgaroside

3-{1-hydroxy-2-[2-hydroxy-2-(hydroxymethyl)-4b,8,8,10a-tetramethyl-tetradecahydrophenanthren-1-yl]ethyl}-5-oxo-2,5-dihydrofuran-2-yl acetic acid

C27H42O7 (478.2930382)

25-Acetylvulgaroside is found in fruits. 25-Acetylvulgaroside is a constituent of Cydonia vulgaris (quince). Constituent of Cydonia vulgaris (quince). 25-Acetylvulgaroside is found in fruits.

Iloprost

2-oxo-2-Phenylethyl 5-[(2Z)-5-hydroxy-4-[(1E)-3-hydroxy-4-methyloct-1-en-6-yn-1-yl]-octahydropentalen-2-ylidene]pentanoic acid

C30H38O5 (478.2719098)

Iloprost is only found in individuals that have used or taken this drug. It is a synthetic analogue of prostacyclin PGI2. Iloprost dilates systemic and pulmonary arterial vascular beds. It is used to treat pulmonary arterial hypertension (PAH).Iloprost is a second generation structural analog of prostacyclin (PGI) with about ten-fold greater potency than the first generation stable analogs, such as carbaprostacyclin. Iloprost binds with equal affinity to human prostacyclin (Prostanoid IP) and prostaglandin EP1 receptors. Iloprost constricts the ilium and fundus circular smooth muscle as strongly as prostaglandin E2 (PGE2) itself. Iloprost inhibits the ADP, thrombin, and collagen-induced aggregation of human platelets. In whole animals, iloprost acts as a vasodilator, hypotensive, antidiuretic, and prolongs bleeding time. All of these properties help to antagonize the pathological changes that take place in the small pulmonary arteries of patients with pulmonary hypertension.

Erinacine D

9-ethoxy-3a,5a-dimethyl-1-(propan-2-yl)-6-[(3,4,5-trihydroxyoxan-2-yl)oxy]-2H,3H,3aH,4H,5H,5aH,6H,9H,10H,10aH-cyclohepta[e]indene-8-carbaldehyde

C27H42O7 (478.2930382)

Erinacine D is found in mushrooms. Erinacine D is a metabolite of Hericium erinaceum (lions mane Metabolite of Hericium erinaceum (lions mane). Erinacine D is found in mushrooms.

(1‐{[1‐carboxylato‐3‐(trimethylammonio)propan‐2‐ yl]oxy}‐1‐oxoicosa‐5,7,11,14‐tetraen‐9‐yl)peroxy

C27H44NO6 (478.31684640000003)

(1‐{[1‐Carboxylato‐3‐(trimethylammonio)propan‐2‐ yl]oxy}‐1‐oxoicosa‐5,7,11,14‐tetraen‐9‐yl)peroxy is an acylcarnitine. More specifically, it is an (1‐carboxynonadeca‐4,6,10,13‐tetraen‐8‐yl)peroxy ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279 ). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (1‐{[1‐Carboxylato‐3‐(trimethylammonio)propan‐2‐ yl]oxy}‐1‐oxoicosa‐5,7,11,14‐tetraen‐9‐yl)peroxy is therefore classified as a long chain AC. As a long-chain acylcarnitine (1‐{[1‐carboxylato‐3‐(trimethylammonio)propan‐2‐ yl]oxy}‐1‐oxoicosa‐5,7,11,14‐tetraen‐9‐yl)peroxy is generally formed through esterification with long-chain fatty acids obtained from the diet. The main function of most long-chain acylcarnitines is to ensure long chain fatty acid transport into the mitochondria (PMID: 22804748 ). Altered levels of long-chain acylcarnitines can serve as useful markers for inherited disorders of long-chain fatty acid metabolism. Carnitine palmitoyltransferase I (CPT I, EC:2.3.1.21) is involved in the synthesis of long-chain acylcarnitines (more than C12) on the mitochondrial outer membrane. Elevated serum/plasma levels of long-chain acylcarnitines are not only markers for incomplete FA oxidation but also are indicators of altered carbohydrate and lipid metabolism. High serum concentrations of long-chain acylcarnitines in the postprandial or fed state are markers of insulin resistance and arise from insulins inability to inhibit CPT-1-dependent fatty acid metabolism in muscles and the heart (PMID: 19073774 ). Increased intracellular content of long-chain acylcarnitines is thought to serve as a feedback inhibition mechanism of insulin action (PMID: 23258903 ). In healthy subjects, increased concentrations of insulin effectively inhibits long-chain acylcarnitine production. Several studies have also found increased levels of circulating long-chain acylcarnitines in chronic heart failure patients (PMID: 26796394 ). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

(20‐{[1‐Carboxylato‐3‐(trimethylammonio)propan‐2‐ yl]oxy}‐20‐oxoicosa‐6,8,12,15‐tetraen‐10‐yl)peroxy

C27H44NO6 (478.31684640000003)

(20‐{[1‐Carboxylato‐3‐(trimethylammonio)propan‐2‐ yl]oxy}‐20‐oxoicosa‐6,8,12,15‐tetraen‐10‐yl)peroxy is an acylcarnitine. More specifically, it is an [(4Z,7Z,11E,13Z)-1-carboxynonadeca-4,7,11,13-tetraen-10-yl]peroxy ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (20‐{[1‐Carboxylato‐3‐(trimethylammonio)propan‐2‐ yl]oxy}‐20‐oxoicosa‐6,8,12,15‐tetraen‐10‐yl)peroxy is therefore classified as a long chain AC. As a long-chain acylcarnitine (20‐{[1‐carboxylato‐3‐(trimethylammonio)propan‐2‐ yl]oxy}‐20‐oxoicosa‐6,8,12,15‐tetraen‐10‐yl)peroxy is generally formed through esterification with long-chain fatty acids obtained from the diet. The main function of most long-chain acylcarnitines is to ensure long chain fatty acid transport into the mitochondria (PMID: 22804748). Altered levels of long-chain acylcarnitines can serve as useful markers for inherited disorders of long-chain fatty acid metabolism. Carnitine palmitoyltransferase I (CPT I, EC:2.3.1.21) is involved in the synthesis of long-chain acylcarnitines (more than C12) on the mitochondrial outer membrane. Elevated serum/plasma levels of long-chain acylcarnitines are not only markers for incomplete FA oxidation but also are indicators of altered carbohydrate and lipid metabolism. High serum concentrations of long-chain acylcarnitines in the postprandial or fed state are markers of insulin resistance and arise from insulins inability to inhibit CPT-1-dependent fatty acid metabolism in muscles and the heart (PMID: 19073774). Increased intracellular content of long-chain acylcarnitines is thought to serve as a feedback inhibition mechanism of insulin action (PMID: 23258903). In healthy subjects, increased concentrations of insulin effectively inhibits long-chain acylcarnitine production. Several studies have also found increased levels of circulating long-chain acylcarnitines in chronic heart failure patients (PMID: 26796394). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

Valyl-leucyl-lysine 4-nitroanilide

N-{5-amino-1-[(4-nitrophenyl)carbamoyl]pentyl}-2-[(2-amino-1-hydroxy-3-methylbutylidene)amino]-4-methylpentanimidate

C23H38N6O5 (478.2903538)

H-D-Val-Leu-Lys-pNA

N-{5-amino-1-[(4-nitrophenyl)carbamoyl]pentyl}-2-[(2-amino-1-hydroxy-3-methylbutylidene)amino]-3-methylpentanimidate

C23H38N6O5 (478.2903538)

Phenacyl 5-[(3aR,4S,5R,6aR)-5-hydroxy-4-[(3R,4S)-3-hydroxy-4-methyloct-1-en-6-ynyl]-3,3a,4,5,6,6a-hexahydro-1H-pentalen-2-ylidene]pentanoate

Phenacyl 5-[(3ar,4S,5R,6ar)-5-hydroxy-4-[(3R,4S)-3-hydroxy-4-methyloct-1-en-6-ynyl]-3,3a,4,5,6,6a-hexahydro-1H-pentalen-2-ylidene]pentanoic acid

C30H38O5 (478.2719098)

Isovitexirone

2beta,3beta,11alpha,14alpha,20R,22R-hexahydroxy-5beta-cholest-7,25-dien-6-one